Outlook Therapeutics, Inc. Investor Rights Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Investor Rights Agreement, dated April 21, 2022, by and between Outlook Therapeutics, Inc. and GMS Ventures and Investments
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2022
Fourth Amendment to Investor Rights Agreement dated September 11, 2017 by and between the Company and BioLexis Pte. Ltd. (formerly GMS Tenshi Holdings Pte. Limited), by and...
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2020
Third Amendment to Investor Rights Agreement dated November 5, 2018
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2018
Second Amendment to Investor Rights Agreement, dated July 18, 2018
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2018
Amendment to Investor Rights Agreement dated May 11, 2018
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
2018
Investor Rights Agreement by and between Oncobiologics, Inc. and the Investor named therein, dated September 11, 2017
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
DE
2017
INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016
INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016
INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014
Investor Rights Agreements
Outlook Therapeutics, Inc.
Biotechnology
NJ
2016